WellSpan York Hospital hosts female interventional cardiologists for women's heart health leadership event
YORK, PA (Feb. 9, 2023) – Top female doctors joined WellSpan’s Dr. Rhian Davies in York earlier today to discuss women’s heart health and participate in three live case demonstrations that were live streamed to additional cardiologists attending across the globe. The event centered on the growing role of female interventional cardiologists in performing complicated procedures. Davies is known for her expertise in performing complicated chronic total occlusions (CTO) at WellSpan York Hospital, one of the top cardiac care hospitals in the country. The event was held at the hospital, and presented by Asahi Intecc, among other partners.
“It’s an honor to be able to share this platform with so many remarkable women in interventional cardiology as we forge a path in what has traditionally been known to be a male-dominated field of medicine,” said Davies. “At WellSpan York Hospital we are pioneering advances in cardiac care and it’s exciting to be sharing that knowledge with institutions around the world.”
Cardiologists in attendance also spent time yesterday in a wire training course known as “Build A Wire”. During the training course, individuals learned about the components of an Asahi Sion Wire and the assembly process. Other events included targeted discussions on innovations in imaging capabilities as well as tools geared specifically to female cardiologists use in procedures to protect from radiation as well as orthopedic injury.
The live case demonstrations held
at the hospital involved patients who are experiencing a blockage in their
artery. The artery has been occluded or obstructed for more than three months,
characterized as a chronic total occlusion. In addition to those at the
hospital, dozens of doctors witnessed the live case virtually across the globe,
including attendees in Bahrain, Japan, Poland, Demark and the United Kingdom.
“Our colleagues in the industry have long known WellSpan to be a destination for cardiac care, and word is quickly spreading to patients of the innovative heart and vascular procedures we perform here,” explained Dr. James Harvey, vice president and chief medical officer of the heart & vascular service line, WellSpan Health. “This event is another example of how WellSpan is leading the way in advanced cardiac care. We’re proud to bring this level of expertise to the communities we serve across South Central Pennsylvania so that our patients can stay close to home for high quality care.”
WellSpan York Hospital is among
the top hospitals in the country, based on the volume of chronic total
occlusion percutaneous coronary interventions, performing approximately 250
annually with referrals from up and down the East Coast.
To learn more about WellSpan’s heart & vascular services, visit www.WellSpan.org/Heart.
To learn more about Asahi Intecc,
visit https://asahi-inteccusa-medical.com/.
About WellSpan Health
WellSpan Health’s vision is to reimagine healthcare through the delivery of comprehensive, equitable health and wellness solutions throughout our continuum of care. As an integrated delivery system focused on leading in value-based care, we encompass more than 2,000 employed providers, 220 locations, eight award-winning hospitals, home care and a behavioral health organization serving South Central Pennsylvania and northern Maryland. With a team 20,000 strong, WellSpan experts provide a range of services, from wellness and employer services solutions to advanced care for complex medical and behavioral conditions. Our clinically integrated network of 2,600 aligned physicians and advanced practice providers is dedicated to providing the highest quality and safety, inspiring our patients and communities to be their healthiest.
About Asahi Intecc
ASAHI Intecc is the leading
partner for physicians performing both simple and complex interventional cases
in the coronary, peripheral, neuro and IR space. Asahi was founded in
1976 and uses select raw materials to distribute sterile medical devices.
The fully in-house production system has established new standards for
precision engineering and device performance. 